Learn More
Cayman Chemical QuIpazInmaleate 100mg

Supplier: Cayman Chemical 42262100 MG
A 5-HT2A, 5-HT2B, and 5-HT2C receptor agonist; induces calcium accumulation in CHO-K1 cells expressing 5-HT2A, 5-HT2B, or 5-HT2C receptors (EC50s = 309.03, 177.83, and 338.84 nM, respectively, for the human receptors); binds to the 5-HT3 receptor (Ki = 2.1 nM); decreases food intake in rats at 2.5, 5, or 10 mg/kg; restores spinal circuitry function, improves gait regularity, and increases interlimb coordination and limb weight-bearing in a rat model of spinal cord transection-induced hindlimb paralysis at 0.3 mg/kg per day in combination with 8-hydroxy DPAT, electrode stimulation of dorsal and lumbar spine regions, and locomotor training
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.